Borapetoside E structure
|
Common Name | Borapetoside E | ||
---|---|---|---|---|
CAS Number | 151200-49-6 | Molecular Weight | 536.568 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 711.1±60.0 °C at 760 mmHg | |
Molecular Formula | C27H36O11 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 383.9±32.9 °C |
Use of Borapetoside EBorapetoside E can be isolated from T. crispa. Borapetoside E improves hyperglycemia, insulin resistance, hepatic steatosis, hyperlipidemia, and oxygen consumption in obese mice. Borapetoside E also inhibits SREBPs expression in the liver and adipose tissue[1]. |
Name | Borapetoside E |
---|---|
Synonym | More Synonyms |
Description | Borapetoside E can be isolated from T. crispa. Borapetoside E improves hyperglycemia, insulin resistance, hepatic steatosis, hyperlipidemia, and oxygen consumption in obese mice. Borapetoside E also inhibits SREBPs expression in the liver and adipose tissue[1]. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 711.1±60.0 °C at 760 mmHg |
Molecular Formula | C27H36O11 |
Molecular Weight | 536.568 |
Flash Point | 383.9±32.9 °C |
Exact Mass | 536.225769 |
PSA | 165.12000 |
LogP | 0.55 |
Vapour Pressure | 0.0±2.4 mmHg at 25°C |
Index of Refraction | 1.605 |
Hazard Codes | Xi |
---|
Methyl (1S,2R,7S,8S,9R)-8-[(2R)-2-(3-furyl)-2-(β-D-glucopyranosyloxy)ethyl]-2,8-dimethyl-10-oxo-11-oxatricyclo[7.2.1.0]dodec-3-ene-3-carboxylate |
1,4-Methano-2-benzoxepin-9-carboxylic acid, 5-[(2R)-2-(3-furanyl)-2-(β-D-glucopyranosyloxy)ethyl]-1,3,4,5,5a,6,7,9a-octahydro-5,9a-dimethyl-3-oxo-, methyl ester, (1S,4R,5S,5aS,9aR)- |